An Update on the Current State of Management and Clinical Trials for IgA Nephropathy

by Chee Kay Cheung, Arun Rajasekaran, Jonathan Barratt, Dana V. Rizk
Published 2021-06-01

The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy

by Dana V. Rizk, Nicolas Maillard, Bruce A. Julian, Barbora Knoppova, Barbora Knoppova, Todd J. Green, Jan Novak, Robert J. Wyatt
Published 2019-03-01

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy.

by William J Placzek, Hiroyuki Yanagawa, Yuko Makita, Matthew B Renfrow, Bruce A Julian, Dana V Rizk, Yusuke Suzuki, Jan Novak, Hitoshi Suzuki
Published 2018-01-01

The origin and activities of IgA1-containing immune complexes in IgA nephropathy

by Barbora eKnoppova, Colin eReily, Nicolas eMaillard, Dana V. Rizk, Zina eMoldoveanu, Jiri eMestecky, Milan eRaska, Milan eRaska, Matthew B. Renfrow, Bruce A. Julian, Jan eNovak
Published 2016-04-01

Confidence in Women’s Health: A Cross Border Survey of Adult Nephrologists

by Elizabeth M. Hendren, Monica L. Reynolds, Laura H. Mariani, Jarcy Zee, Michelle M. O’Shaughnessy, Andrea L. Oliverio, Nicholas W. Moore, Peg Hill-Callahan, Dana V. Rizk, Salem Almanni, Katherine E. Twombley, Emily Herreshoff, Carla M. Nester, Michelle A. Hladunewich
Published 2019-02-01